The IC50 for Inhibition of Digoxin Transport Across Confluent Cell Monolayers of P-Gp Expressing Cell Lines Is Often a Function of Inhibitor Binding to Both P-Gp and an Unidentified Basolateral Digoxin Uptake Transporter

Biophysical Journal - United States
doi 10.1016/j.bpj.2012.11.642
Full Text
Abstract

Available in full text

Categories
Biophysics
Date
Authors
Publisher

Elsevier BV

Related search

Transport Inhibition of Digoxin Using Several Common P-Gp Expressing Cell Lines Is Not Necessarily Reporting Only on Inhibitor Binding to P-Gp

PLoS ONE
Multidisciplinary
2013English

Cannabidiol Changes P-Gp and BCRP Expression in Trophoblast Cell Lines

PeerJ
GeneticsMolecular BiologyBiochemistryBiological SciencesMedicineAgriculturalNeuroscience
2013English

PBPK Models for CYP3A4 and P-Gp DDI Prediction: A Modeling Network of Rifampicin, Itraconazole, Clarithromycin, Midazolam, Alfentanil and Digoxin

CPT: Pharmacometrics and Systems Pharmacology
ModelingSimulationCardiovascular MedicinePharmacologyCardiology
2018English

Inhibition of P-Glycoprotein Mediated Drug Transport : A Unifying Mechanism to Explain the Interaction Between Digoxin and Quinidine

Circulation
Cardiovascular MedicinePhysiologyCardiology
1999English

P-Gp and Taxanes

Oncoscience
Cancer ResearchOncology
2014English

P-Glycoprotein (P-Gp) Is Upregulated in Peripheral T-Cell Subsets From Solid Organ Transplant Recipients

Journal of Clinical Pharmacology
Pharmacology
2001English

P Glycoprotein (ABCB1; MDR1; P-Gp)

Science-Business eXchange
2009English

Recent Developments of P-Gp Inhibitors

2013English

P Glycoprotein (MDR1; ABCB1; P-Gp; CD243)

Science-Business eXchange
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy